News & Views
News,
Telix is delighted to announce the appointment of Darren Patti as Chief Operating Officer, Telix Pharmaceuticals US (Inc). Darren brings with him over 15 years’ experience in radiopharmacy network management and…
Read more
Telix announces it has extended its non-exclusive global clinical and commercial supply agreements with Garching-based ITM…
Read more
News,
Telix is delighted to announce the appointment of Sébastien Linard to the position of General Manager of Telix’s European Manufacturing in Seneffe,…
Read more
Telix Pharmaceuticals Limited Releases Full-Year 2020 Results and 2020 Annual…
Read more
Telix Japan receives Clinical Trial Notification (CTN) clearance to commence a Phase I trial of its prostate cancer imaging product in…
Read more
Telix to present the Company’s FY2020 results together with an update on Telix’s…
Read more
Telix announces the Ministry of Health of the Czech Republic is the first European health authority to grant a national authorization allowing the use of…
Read more
Telix announces research cooperation agreement with Heidelberg University Hospital to develop next-generation theranostic radiopharmaceuticals for urologic…
Read more
Telix CEO, Dr Christian Behrenbruch recently facilitated an international expert panel discussion at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Mid-Winter Symposium entitled: “Ga-68 PSMA-11: Advances in Technology,…
Read more